Home » Posts tagged 'morgan sindall'
Tag Archives: morgan sindall
Dr David Paul of VectorVest discusses VectorVest market timing indicator, CWD, MGNS, COA, III and HSTG on Core Finance TV
Dr David Paul, Managing Director VectorVest arrived with the news that since July 19th the VectorVest Market timing indicator has turned positive. This was after just two weeks in bear mode. Stocks discussed include Countryside Properties (CWD), Morgan Sindall (MGNS), Coats Group (COA), 3i Group (III) and Hastings Group (HSTG).
Dr David Paul, MD at VectorVest speaks with host Zak Mir regarding the Buy/Sell Ratio and Market Timing Indicator trending in the wrong direction, thus the word of caution – the markets are on thin ice. However, should the market turn around, David shows us some shares to keep an eye on: Countryside Properties (CSP), Morgan Sindall (MGNS), Coats Group (COA) and more!
London-based Morgan Sindall Plc, (MGNS.L) is engaged in construction and regeneration via five operating divisions: Fit Out, Construction, Infrastructure Services, Affordable Housing, and Urban Regeneration. The Fit Out division involves in the refurbishment and fit out of office accommodation. It also fits out and refurbishes hotel, retail, leisure, and education facilities, as well as supplies and installs commercial office furniture. The Construction division engages in construction activities ranging from small works, repair, and maintenance services to large scale complex projects in the airport, defense, commercial, education, industrial, healthcare, leisure, and retail sectors. This division also offers management services to the manufacturing, environmental, nuclear, transport, and public sectors. The Infrastructure Services division designs and delivers complex projects in the road, air, rail, water, and energy sectors; maintains utility networks in the water, gas, and electricity sectors; and offers tunneling services, as well as provides project, program, and integration management consultancy services. The Affordable Housing division develops, constructs, and refurbishes social and open market affordable housing in England, Scotland, and Wales. The Urban Regeneration division develops large-scale mixed use urban regeneration projects in the office, industrial, residential, leisure, and ancillary retail sectors.
FREE! For free VectorVest analysis on any stock, go to this link here
On May 4th 2017, MGNS issued a trading update with its AGM statement. The Company said trading for the financial year to date has been strong, with the positive momentum entering the year continuing throughout the period. Each division has performed as expected, with the overall Company result being driven by further margin and profit growth in Fit Out and the expected margin improvement in Construction & Infrastructure. The committed order book as at 31 March 2017 was up 5% to £3.83bn from the year-end position, while the regeneration & development pipeline was up 2% to £3.28bn. Also at 31 March, the Company had net cash of £115m, with an average daily net cash from the start of the year to 31 March of £154m, higher than previously expected due primarily to better working capital management in Construction & Infrastructure and Fit Out. As a result, the Company now expects that the average daily net cash for the year will be in excess of £50m and, consequently, the net interest charge for the year will be lower than was previously anticipated. Accordingly, MGNS is on track to deliver 2017 full year results slightly ahead of its previous expectations set at the 2016 full year results on 23 February 2017.
While MGNS has long been a favourite of the VectorVest team, the company continues to grow at pace, thanks to an exceptionally strong set of metrics. The VectorVest GRT (Earnings Growth Rate), which reflects a company’s one to three year forecasted earnings growth rate in percent per year, currently shows forecasted GRT for MGNS of 27.00%, which VectorVest considers to be excellent. In addition, the VST – the VST-Vector master indicator for ranking every stock in the VectorVest database, logs MGNS at 1.48, which is excellent on a scale of 0.00 to 2.00. From a valuation standpoint, VectorVest logs a current rating of 1,741p per share, indicating MGNS is significantly undervalued at its current 1,252p.
The chart of MGNS.L is shown above where the price is plotted in candlestick format. The green line study above the price is the VectorVest calculated valuation while the blue line study in the window below the price is earnings per share (EPS). The trend as defined by Charles Dow is upwards. This is shown by the series of rising bottoms charted by the price.
Of note is that the last swing low charted on the 22nd May is considerably higher than the swing high charted on the 26th April. Mr Dow defined this as a “strong trend” as the market failed to retreat to a point where the last resistance became support. This is very positive and the probabilities both technically and fundamentally favor a breakout of the 52 week high soon. The share has been on a VectorVest Buy recommendation since late December 2016.
Summary: There is a sense of an almost unstoppable growth momentum at MGNS, with clear visibility in earnings growth thanks to bursting forward order books. Added to this, the Company enjoys a continual strengthening in its daily net cash position, something most companies can only dream of. As such MGNS takes its rightful place on the VectorVest shortlist of top growth company picks.
June 7th 2017
Readers can examine trading opportunities on MGNS and a host of other similar stocks for a single payment of £5.95. This gives access to the VectorVest Risk Free 5-week trial, where members enjoy unlimited access to VectorVest UK & U.S., plus VectorVest University for on-demand strategies and training. Link here to view.
FREE! For free VectorVest analysis on any stock, go to this link here
On VectorVest a simple search using the Unisearch tool will quickly find shares that are undervalued with good fundamentals that have just issued a Buy recommendation. This will give the active trader a short list of many high probability trading opportunities each week. Traders now have the opportunity to spend five weeks discovering VectorVest’s unique simplicity, automation and independent guidance. Just £5.95 buys a 5 week trial to enable deep exploration, or how the system can assist in smarter trading in as little as 10 minutes a day. Powerful tools. Proven strategies. Unique Perspectives.
Link here for more info and to set up a trial.
European Financial Publishing Limited T/A VectorVest UK (VectorVest) is authorised and regulated by the Financial Conduct Authority under register number 543038. You should remember that the value of investments and the income derived therefrom may fall as well as rise and you may not get back the amount that you invest. Past performance is not a reliable guide to the future. This material is directed only at persons in the UK and is not an offer or invitation to buy or sell securities. If investors are in any doubt of the suitability of an investment given their individual circumstances, they are recommended to contact an investment manager or independent financial adviser who may be able to provide tailored advice. Opinions expressed whether in general or both on the performance of individual securities and in a wider economic context represent the views of VectorVest at the time of preparation. They are subject to change and should not be interpreted as investment advice. VectorVest and connected companies, clients, directors, employees and other associates, may have a position in any security, or related financial instrument, issued by a company or organisation mentioned on this site. European Financial Publishing Limited is a company incorporated in Scotland under Company Number SC357322 with its registered address at Exchange Tower, 19 Canning Street, Edinburgh EH3 8EH. Email: support@VectorVest.com
Dr David Paul talks VectorVest Composite index, plus AIM stocks BXP, MGNS, DFX, VCP with Jeremy Naylor on IG TV
Dr David Paul discusses the VectorVest Composite index, market timing plus AIM stock picks: Beximco Pharma (BXP), Morgan Sindall (MGNS), Defenx (DFX) and Victoria (VCP) with Jeremy Naylor on IG TV.
Dr David Paul, MD of VectorVest discusses Sopheon (SPE), Triad Group (TRD), Defenx (DFX) & Morgan Sindall (MGNS) on TipTV
Dr. David Paul, MD at Vector Vest talks about VectorVest Edge Strategy, which involves screening shares for favourable technical and fundamental factors and buying them when the overall market is rising. Stocks discussed today include Sopheon (SPE), Triad Group (TRD), Defenx (DFX), Morgan Sindall (MGNS).